摘要
背景:肺动脉高压是影响人类健康的慢性疾病之一。微囊泡通过与受体细胞融合,将脂质、蛋白质、RNA等生物活性分子转移到靶细胞中,参与细胞之间的通信。微囊泡参与多种生物过程,具有调节免疫、促进血管生成等功能。来自各种细胞的微囊泡可能成为该疾病的诊断生物标志物或治疗靶点。因此,探索微囊泡介导的细胞通信的作用已成为肺动脉高压的潜在治疗靶点。 目的:阐明微囊泡在细胞通信中的分类、特征和机制,并探讨微囊泡介导的细胞通信在肺动脉高压中潜在的重要作用。 结果:炎症是肺动脉高压的重要发病机制。许多研究表明,来自不同细胞的微泡可以通过转移肺动脉高压中包含的炎症因子来参与肺动脉高压的病理过程。 结论:微泡介导的细胞通讯可能成为肺动脉高压的治疗靶点
关键词: 微囊泡、细胞外囊泡、细胞通讯、巨噬细胞来源的微囊泡、肺动脉高压、炎症。
Current Medicinal Chemistry
Title:Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension
Volume: 28 Issue: 23
关键词: 微囊泡、细胞外囊泡、细胞通讯、巨噬细胞来源的微囊泡、肺动脉高压、炎症。
摘要:
Background: Pulmonary arterial hypertension is one of the chronic diseases that affect human health. Microvesicles participate in the communication between cells by fusing with the recipient cells to transfer the bioactive molecules, such as lipids, proteins, RNA, etc., to the target cells. Microvesicles are involved in various biological processes and have the functions of regulating immunity, promoting angiogenesis, and so on. Microvesicles derived from various cells may become the diagnostic biomarkers or therapeutic targets for the diseases. Therefore, exploring the role of microvesicles-mediated cell communication has become a potential therapeutic target for pulmonary arterial hypertension.
Objective: It is to clarify the classification, features, and mechanism of microvesicles in cell communication and to discuss the potentially important roles of microvesicles-mediated cell communication in pulmonary arterial hypertension.
Results: Inflammation is an important pathogenesis of pulmonary arterial hypertension. Many studies have shown that microvesicles from different cells can participate in the pathological process of pulmonary arterial hypertension by transferring the inflammatory factors contained in them.
Conclusion: Microvesicles-mediated cell communication may become the therapeutic target for pulmonary arterial hypertension.
Export Options
About this article
Cite this article as:
Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867328666201124152406
DOI https://dx.doi.org/10.2174/0929867328666201124152406 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Secondary Prevention of Atherothrombotic Cerebrovascular Events
Current Vascular Pharmacology Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: A Possible Role of Leptin
Current Pharmaceutical Design Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated Protein Kinase (AMPK) Activators
Letters in Drug Design & Discovery Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Carbonic Anhydrase Inhibition: Insight into Non-COX-2 Pharmacological Effect of some Coxibs
Current Pharmaceutical Design Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Current Pharmaceutical Design Augmentation of Creatine in the Heart
Mini-Reviews in Medicinal Chemistry Medication Adherence and Associated Factors among Chronic Heart Failure Clients on Follow Up Oromia Region, West Ethiopia
Cardiovascular & Hematological Agents in Medicinal Chemistry Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews Role of Nitric Oxide and Mitochondrial Nitric Oxide Synthase in Energy Adaptive Responses
Current Cardiology Reviews Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Hematopoietic Colony Stimulating Factors in Cardiovascular and Pulmonary Remodeling: Promoters or Inhibitors?
Current Pharmaceutical Design Stenting Renal Artery Stenosis: What is the Fuss All About?
Reviews on Recent Clinical Trials Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes
Current Pharmaceutical Design Plasma Angiotensin-(1-7) is a Potential Biomarker for Alzheimer’s Disease
Current Neurovascular Research Phylogenetic Aspects of Nucleobindin-2/Nesfatin-1
Current Pharmaceutical Design Modulators of the Vascular Endothelin Receptor in Blood Pressure Regulation and Hypertension
Current Molecular Pharmacology Study of Prolactin Permeation Through the Pericardium and Its Bioavailability
Protein & Peptide Letters Pros and Cons of Aggressive Blood Pressure Lowering in Patients with Type 2 Diabetes
Current Vascular Pharmacology